Anti-inflammatory effects of orally administered glucosamine oligomer in an experimental model of inflammatory bowel disease

Carbohydrate Polymers

Volumn 115, Issue , 2015, Pages 448-456

  Azuma, Kazuo ^a   Osaki, Tomohiro ^a   Kurozumi, Seiji ^b   Kiyose, Masatoshi ^b   Tsuka, Takeshi ^a   Murahata, Yusuke ^a   Imagawa, Tomohiro ^a   Itoh, Norihiko ^a   Minami, Saburo ^a   Sato, Kimihiko ^b   Okamoto, Yoshiharu ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Koyo Chemical Co Ltd   (Japan)

Author keywords

Anti inflammatory; Functional food; Glucosamine oligomers; Inflammatory bowel disease; Nuclear factor kappa B

Indexed keywords

CHEMICAL ACTIVATION; GLUCOSAMINE; MAMMALS; NITRIC OXIDE; OLIGOMERS;

ANTI-INFLAMMATORIES; ANTI-INFLAMMATORY EFFECTS; EXPERIMENTAL MODELING; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLAMMATORY BOWEL DISEASE; NUCLEAR FACTOR KAPPAB; PRO-INFLAMMATORY CYTOKINES; TUMOR NECROSIS FACTOR ALPHA;

FUNCTIONAL FOOD;

ANTIINFLAMMATORY AGENT; CHITIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGOCHITOSAN;

ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; COLON; DISEASE MODEL; DRUG EFFECTS; FEMALE; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PATHOLOGY; SURVIVAL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; CHITIN; COLON; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; NF-KAPPA B; ORGAN SIZE; SURVIVAL ANALYSIS;

EID: 84907494859     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2014.09.012     Document Type: Article

References (38)

1. L.F. Araujo, A.M. Soeiro, J.L. Fernandes, and C.V. Serrano Jr. Cardiovascular events: A class effect by COX-2 inhibitors Arquivos Brasileiros de Cardiologia 85 2005 222 229
2. K. Azuma, T. Osaki, S. Ifuku, H. Saimoto, T. Tsuka, and T. Imagawa α-Chitin nanofibrils improve inflammatory and fibrosis responses in mice with inflammatory bowel disease Carbohydrate Polymers 90 2012 197 200
3. K. Azuma, T. Osaki, T. Wakuda, S. Ifuku, H. Saimoto, and T. Tsuka Beneficial and preventive effect of chitin nanofibrils in a dextran sulfate sodium-induced acute ulcerative colitis model Carbohydrate Polymers 87 2012 1399 1403
4. M. Coëffier, R. Marion-Letellier, and P. Déchelotte Potential for amino acids supplementation during inflammatory bowel diseases Inflammatory Bowel Disease 16 2010 518 524
5. R.K. Cross, and K.T. Wilson Nitric oxide in inflammatory bowel disease Inflammatory Bowel Disease 9 2003 179 189
6. C.O. Elson, Y. Cong, V.J. McCracken, R.A. Dimmitt, R.G. Lorenz, and C.T. Weaver Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota Immunological Reviews 206 2005 260 276
7. K. Goh, and S.D. Xiao Inflammatory bowel disease: A survey of the epidemiology in Asia Journal of Digestive Disease 10 2009 1 6
8. M.B. Grisham, K.P. Pavlick, F.S. Laroux, J. Hoffman, S. Bharwani, and R.E. Wolf Nitric oxide and chronic gut inflammation: controversies in inflammatory bowel disease Journal of Investigative Medicine 50 2002 272 283
9. K.V. Harish-Prashanth, and K.V. Tharanathan Depolymerized products of chitosan as potent inhibitors of tumor-induced angiogenesis Biochimica et Biophysica Acta 1722 2005 22 29
10. C.M. Hogaboam, K. Jacobson, S.M. Collins, and M.G. Blennerhassett The selective beneficial effects of nitric oxide inhibition in experimental colitis American Journal of Physiology 268 1995 G673 G684
11. R. Huang, E. Mendis, N. Rajapakse, and S.K. Kim Strong electronic charge as an important factor for anticancer activity of chitooligosaccharides (COS) Life Science 78 2006 2399 2408
12. T. Karrasch, and T. Jobin NF-κB and the intestine: Friend or foe? Inflammatory Bowel Disease 14 2008 114 124
13. L. Kruidenier, I. Kuiper, C.B. Lamers, and H.W. Verspaget Intestinal oxidative damage in inflammatory bowel disease: Semi-quantification, localization, and association with mucosal antioxidants Journal of Pathology 201 2003 28 36
14. Y. Li, H. Liu, Q.S. Xu, Y.G. Du, and J. Xu Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-κB and endothelial inflammatory response Carbohydrate Polymers 99 2014 568 578
15. A.R. Martín, I. Villegas, M. Sánchez-Hidalgo, and C.A. de la Lastra The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model British Journal of Pharmacology 147 2006 873 885
16. S. Masuda, K. Azuma, S. Kurozumi, M. Kiyose, T. Osaki, and T. Tsuka Anti-tumor properties of orally administered glucosamine and N-acetyl-d-glucosamine oligomers in a mouse model Carbohydrate Polymers 111 2014 783 787
17. S. Melgar, A. Karlsson, and E. Michaëlsson Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: Correlation between symptoms and inflammation American Journal of Physiology Gastrointestinal and Liver Physiology 288 2005 G1328 G1338
18. G. Morrison, B. Headon, and P. Gibson Update in inflammatory bowel disease Australian Family Physician 38 2009 956 961
19. Y. Naito, T. Takagi, and T. Yoshikawa Neutrophil-dependent oxidative stress in ulcerative colitis Journal of Clinical Biochemistry and Nutrition 41 2007 18 26
20. K. Nakamura, K. Honda, T. Mizutani, H. Akiho, and N. Harada Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules World Journal of Gastroenterology 12 2006 4628 4635
21. T. Ohkawara, J. Nishihira, H. Takeda, K. Miyashita, K. Kato, and M. Kato Geranylgeranylacetone protects mice from dextran sulfate sodium-induced colitis Scandinavian Journal of Gastroenterology 40 2005 1049 1057
22. Y. Ohtsuka, J. Lee, D.S. Stamm, and I.R. Sanderson MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine Gut 49 2001 526 533
23. A.B. Pithadia, and S. Jain Treatment of inflammatory bowel disease (IBD) Pharmacological Reports 63 2011 629 642
24. N. Rajendran, and D. Kumar Role of diet in the management of inflammatory bowel disease World Journal of Gastroenterology 16 2010 1442 1448
25. D.J. Rose, M.T. DeMeo, A. Keshavarzian, and B.R. Hamaker Influence of dietary fiber on inflammatory bowel disease and colon cancer: Importance of fermentation pattern Nutrition Reviews 65 2007 51 62
26. M.A. Rosillo, M. Sanchez-Hidalgo, A. Cárdeno, and C.A. de la Lastra Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease Biochemical Pharmacology 82 2011 737 745
27. M. Sasaki, J.W. Elrod, P. Jordan, M. Itoh, T. Joh, and A. Minagar CYP450 dietary inhibitors attenuate TNF-alpha-stimulated endothelial molecule expression and leukocyte adhesion American Journal of Physiology Cell Physiology 286 2004 C931 C939
28. R.K. Schindhelm, L.P. van der Zwan, T. Teerlink, and P.G. Scheffer Myeloperoxidase: A useful biomarker for cardiovascular disease risk stratification? Clinical Chemistry 55 2009 1462 1470
29. K.T. Shen, M.H. Chen, H.Y. Chan, J.H. Jeng, and Y.J. Wang Inhibitory effects of chitooligosaccharides on tumor growth and metastasis Food and Chemical Toxicology 47 2009 1864 1871
30. K. Suzuki, T. Mikami, Y. Okawa, A. Tokoro, S. Suzuki, and M. Suzuki Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose Carbohydrate Research 151 1986 403 408
31. A. Tokoro, N. Tatewaki, T. Mikami, S. Suzuki, and M. Suzuki Effect of NACOS-6 on lymphokine-activated killer cell (LAK) activity Biotherapy 3 1989 51 54
32. C.Y. Tsai, T.S. Lee, Y.R. Kou, and Y.L. Wu Glucosamine inhibits IL-1beta-mediated IL-8 production in prostate cancer cells by MAPK attenuation Journal of Cell Biochemistry 108 2009 489 498
33. C. Vanderpool, F. Yan, and D.B. Polk Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases Inflammatory Bowel Disease 14 2008 1585 1596
34. S.L. Wang, H.T. Lin, T.W. Liang, Y.J. Chen, Y.H. Yen, and S.P. Guo Reclamation of chitinous materials by bromelain for the preparation of antitumor and antifungal materials Bioresource Technology 99 2008 4386 4393
35. P. Wei, P. Ma, Q.S. Xu, Q.H. Bai, J.G. Gu, and H. Xi Chitosan oligosaccharides suppress production of nitric oxide in lipopolysaccharide-induced N9 murine microglial cells in vitro Glycoconjugate Journal 29 2012 285 295
36. Y.L. Wu, Y.R. Kou, H.L. Ou, H.Y. Chien, K.H. Chuang, and H.H. Liu Glucosamine regulation of LPS-mediated inflammation in human bronchial epithelial cells European Journal of Pharmacology 635 2010 219 226
37. S. Yomogida, Y. Kojima, Y. Tsutsumi-Ishii, J. Hua, K. Sakamoto, and I. Nagaoka Glucosamine, a naturally occurring amino monosaccharide, suppresses dextran sulfate sodium-induced colitis in rats International Journal of Molecular Medicine 22 2008 317 323
38. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: Therapeutic efficacy and possible mechanisms of action